Fas/Apo-1 (CD95)-Mediated Apoptosis of Neutrophils with Fas Ligand (CD95L)-Expressing Tumors Is Crucial for Induction of Inflammation by Neutrophilic Polymorphonuclear Leukocytes Associated with Antitumor Immunity

This publication has 39 references indexed in Scilit:

• Fas‐induced apoptosis, and diseases caused by its abnormality
  Genes to Cells, 1996
• Prevention of Islet Allograft Rejection with Engineered Myoblasts Expressing FasL in Mice
  Science, 1996
• Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege
  Science, 1995
• A role for CD95 ligand in preventing graft rejection
  Nature, 1995
• Fas and Fas ligand: lpr and gld mutations
  Immunology Today, 1995
• Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor family
  Cell, 1993
• Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis
  Nature, 1992
• Lpr and gld: Single Gene Models of Systemic Autoimmunity and Lymphoproliferative Disease
  Annual Review of Immunology, 1991
• The proteins encoded by the VpreB and lambda 5 pre-B cell-specific genes can associate with each other and with mu heavy chain.
  The Journal of Experimental Medicine, 1990
• Mac‐1: a macrophage differentiation antigen identified by monoclonal antibody
  European Journal of Immunology, 1979